Egetis Therapeutics AB (EGTX.ST) Q4 2025 Earnings

25NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.3
-0.25
-0.21
-0.16

Details

Expected EPS
-0.196844076585
Actual EPS
-0.23217506469000002
Surprise EPS
-0.04
Surprise Percent
+17.95%

Description

Egetis Therapeutics AB (EGTX.ST) has reported earnings of -0.23217506469000002 per share for Q4 2025.

0 Comments

Share your thoughts